Correlogic/Predicant Conflict Of Interest Would Be Prevented Under Reform
This article was originally published in The Gray Sheet
Executive Summary
Potential conflicts of interest, such as those between the National Cancer Institute, Correlogic and Predicant would have been identified and prevented under proposed NIH ethics reforms presented by Director Elias Zerhouni, NCI officials testified at a June 22 House Energy & Commerce Committee hearing